The Group B Streptococcus Infection Treatment market size is expected to reach $1.89 billion in 2030 at a CAGR of 8.6%, driven by rising healthcare expenditure.
Read More
The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market size is expected to reach $5.88 billion in 2030 at a CAGR of 18.9%, driven by rising cell and gene therapy trials.
Read More
The Gene Therapy Bioassays market size is expected to reach $2.62 billion in 2030 at a CAGR of 16.7%, driven by rising gene therapy clinical trials.
Read More
The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market size is expected to reach $2.42 billion in 2030 at a CAGR of 32.9%, driven by rising myeloma prevalence.
Read More
The Epitranscriptomic Therapies market size is expected to reach $4.2 billion in 2030 at a CAGR of 21.9%, driven by increasing demand for personalized medicine.
Read More
The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology market size is expected to reach $8.77 billion in 2030 at a CAGR of 23.5%, driven by rising adoption of genomics and personalized medicine.
Read More
The Epidermal Growth Factor Receptor (EGFR) Non-Small Cell Lung Cancer market size is expected to reach $13.74 billion in 2030 at a CAGR of 8.1%, driven by increasing focus on personalized medicine approaches.
Read More
The Dual-Chamber Serum Bottle market size is expected to reach $1.98 billion in 2030 at a CAGR of 7.9%, driven by rising demand in cosmetics and personal care.
Read More
The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery market size is expected to reach $15.22 billion in 2030 at a CAGR of 12.5%, driven by rising demand for personalized medicine.
Read More
The Clear Cell Ovarian Cancer market size is expected to reach $3.15 billion in 2030 at a CAGR of 8.5%, driven by increasing adoption of targeted therapies.
Read More